StonvexLoading…
StonvexStonvexStonvexCore line items from BCYC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $887.00K | $72.59M | $24.63M | $12.90M |
Operating Income | $-65.48M | $-247.06M | $-222.36M | $-156.81M |
Net Income | $-60.83M | $-218.96M | $-198.81M | $-78.95M |
EPS (Diluted) | $-0.87 | $-3.16 | $-2.87 | $-2.02 |
Total Assets | $652.40M | $717.60M | $763.95M | $832.18M |
Total Liabilities | $98.08M | $107.62M | $145.47M | $163.27M |
Cash & Equivalents | $559.47M | $628.11M | $648.33M | $721.45M |
Free Cash Flow OCF − CapEx | $-66.64M | $-252.03M | $-232.10M | $-160.26M |
Shares Outstanding | 69.71M | 69.37M | 69.31M | 69.25M |